Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -106.58% is 68% above its 5-year average of -334.90%, near the high end of its 5-year range (-1208.05%–-48.04%).
0.16% below its 12-month average of -106.41%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -90.85%.
NET PROFIT MARGIN
-106.58%
NET PROFIT MARGIN AVG TTM
-106.41%
NET PROFIT MARGIN AVG 3Y
-248.41%
NET PROFIT MARGIN AVG 5Y
-334.90%
NET PROFIT MARGIN AVG 10Y
-316.95%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.16%
CURRENT VS 3Y AVG
+57.10%
CURRENT VS 5Y AVG
+68.18%
CURRENT VS 10Y AVG
+66.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bionano Genomics, Inc.
Market Cap
$16.75M
Net Profit Margin
-106.58%
TTM Avg
-106.41%
3Y Avg
-248.41%
5Y Avg
-334.90%
Market Cap
$16.86M
Net Profit Margin
-219.50%
TTM Avg
-381.91%
3Y Avg
-332.62%
5Y Avg
-409.39%
Market Cap
$16.22M
Net Profit Margin
0.00%
TTM Avg
-6850.00%
3Y Avg
-4251.62%
5Y Avg
-4766.26%
Market Cap
$17.39M
Net Profit Margin
-755.13%
TTM Avg
-243.50%
3Y Avg
-516.28%
5Y Avg
-344.84%
Market Cap
$15.80M
Net Profit Margin
-3575.07%
TTM Avg
-1754.85%
3Y Avg
-877.42%
5Y Avg
-584.95%
Market Cap
$15.57M
Net Profit Margin
-3011.52%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-79.84%
Market Cap
$17.76M
Net Profit Margin
-706.23%
TTM Avg
-81.41%
3Y Avg
-315.86%
5Y Avg
-1797.64%
Market Cap
$15.38M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-2405.08%
Market Cap
$14.74M
Net Profit Margin
-153.28%
TTM Avg
-93.42%
3Y Avg
-97.51%
5Y Avg
-105.13%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.75M | -106.58% | -106.41% | -248.41% | -334.90% |
| Dyadic International, Inc. (DYAI)vs › | $16.86M | -219.50% | -381.91% | -332.62% | -409.39% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 0.00% | -6850.00% | -4251.62% | -4766.26% |
| Lipocine Inc. (LPCN)vs › | $17.39M | -755.13% | -243.50% | -516.28% | -344.84% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.80M | -3575.07% | -1754.85% | -877.42% | -584.95% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.57M | -3011.52% | 0.00% | 0.00% | -79.84% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.76M | -706.23% | -81.41% | -315.86% | -1797.64% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.38M | 0.00% | 0.00% | 0.00% | -2405.08% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.74M | -153.28% | -93.42% | -97.51% | -105.13% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -651.27% | 0.00% | 0.00% | 0.00% |
Operating Margin
-117.0%
Net Profit Margin
-106.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -90.85% |
| 2026-03-31 | -124.17% |
| 2025-12-31 | -99.77% |
| 2025-09-30 | -115.42% |
| 2025-06-30 | -101.84% |
| 2025-03-31 | -48.04% |
| 2024-12-31 | -246.54% |
| 2024-09-30 | -728.57% |
| 2024-06-30 | -208.78% |
| 2024-03-31 | -358.33% |
| 2023-12-31 | -409.39% |
| 2023-09-30 | -1208.05% |
| 2023-06-30 | -449.23% |
| 2023-03-31 | -500.66% |
| 2022-12-31 | -470.81% |
| 2022-09-30 | -440.51% |
| 2022-06-30 | -482.13% |
| 2022-03-31 | -525.84% |
| 2021-12-31 | -364.15% |
| 2021-09-30 | -445.82% |
| 2021-06-30 | -487.19% |
| 2021-03-31 | -313.98% |
| 2020-12-31 | -293.99% |
| 2020-09-30 | -491.44% |
| 2020-06-30 | -683.08% |
| 2020-03-31 | -925.18% |
| 2019-12-31 | -283.26% |
| 2019-09-30 | -193.12% |
| 2019-06-30 | -352.45% |
| 2019-03-31 | -423.79% |
| 2018-12-31 | -159.75% |
| 2018-09-30 | -174.15% |
| 2018-06-30 | -97.68% |
| 2018-03-31 | -217.55% |
| 2017-12-31 | -208.07% |
| 2017-09-30 | -185.39% |
| 2017-06-30 | -303.92% |
| 2017-03-31 | -330.41% |
